Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 8/20 | 0.40 |
| ▸ | CA2 | P00918 | 8/20 | 0.40 |
| ▸ | CA9 | Q16790 | 7/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.40 |
| ▸ | CA3 | P07451 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | CA6 | P23280 | 2/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27805555 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL27805552 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL27826191 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL27826184 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL2563068 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL27826190 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL27826182 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL8935552 | 1.00 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL8668225 | 0.98 | — | — | |
| SCHEMBL27826296 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4627082-A1 | TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250250568-A1 | MODIFIED OLIGONUCLEOTIDES | EMPIRICO INC (US) | 2025-08-07 | — | — | US | disclosed |
| US-20250188455-A1 | LIPOPHILIC OLIGONUCLEOTIDE CONJUGATES | VANDERBILT UNIVERSITY | 2025-06-12 | — | — | US | disclosed |
| US-12258563-B2 | Modified oligonucleotides | EMPIRICO INC. (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025059326-A1 | MODIFIED OLIGONUCLEOTIDES | EMPIRICO INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4499834-A2 | MODIFIED OLIGONUCLEOTIDES | EMPIRICO INC. (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-119278265-A | Modified oligonucleotides | 艾姆皮瑞克公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240409938-A1 | LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | VANDERBILT UNIVERSITY | 2024-12-12 | — | — | US | disclosed |
| US-20240271130-A1 | LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF INFLAMMATORY DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-08-15 | — | — | US | disclosed |
| US-20240264142-A1 | MOLECULAR DETECTION AND COUNTING USING NANOPORES | ROCHE SEQUENCING SOLUTIONS INC (US) | 2024-08-08 | — | — | US | disclosed |
| EP-3526349-B1 | MOLECULAR DETECTION AND COUNTING USING NANOPORES | HOFFMANN LA ROCHE (CH) | 2021-03-17 | — | — | EP | disclosed |
| EP-3464310-B1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | HOFFMANN LA ROCHE (CH) | 2021-01-27 | — | — | EP | disclosed |
| US-20200377944-A1 | COMPOSITIONS AND METHODS FOR UNIDIRECTIONAL NUCLEIC ACID SEQUENCING | ROCHE SEQUENCING SOLUTIONS INC (US) | 2020-12-03 | — | — | US | disclosed |
| US-20200263248-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | Roche Sequencing Solutions, Inc. (US) | 2020-08-20 | — | — | US | disclosed |
| US-10655174-B2 | Tagged multi-nucleotides useful for nucleic acid sequencing | Roche Sequencing Solutions, Inc. (US) | 2020-05-19 | — | — | US | disclosed |
| US-20190250142-A1 | MOLECULAR DETECTION AND COUNTING USING NANOPORES | Roche Sequencing Solutions, Inc. | 2019-08-15 | — | — | US | disclosed |
| US-20190241952-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | ROCHE SEQUENCING SOLUTIONS INC (US) | 2019-08-08 | — | — | US | disclosed |
| US-20170342485-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | Roche Sequencing Solutions, Inc. (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170153257-A1 | METHODS OF ESTIMATING LOGD OF TAGGED COMBINATORIAL LIBRARY COMPOUNDS | DICE MOLECULES SV, LLC | 2017-06-01 | — | — | US | disclosed |
| WO-2017062973-A2 | METHODS OF ESTIMATING LOGD OF TAGGED COMBINATORIAL LIBRARY COMPOUNDS | DICE MOLECULES SV, LLC (US) | 2017-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10655174-B2 | Tagged multi-nucleotides useful for nucleic acid sequencing | NT5C3B, POLN, RNGTT | HTT 1443/4885MEN1 4287/4885THRB 4373/4885 |
| US-12258563-B2 | Modified oligonucleotides | TRDMT1, NSUN3, PHAX | HTT 1274/4885MEN1 4299/4885THRB 3420/4885 |
| US-20190241952-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | NT5C3B, POLN, RNGTT | HTT 1443/4885MEN1 4287/4885THRB 4373/4885 |
| US-20170153257-A1 | METHODS OF ESTIMATING LOGD OF TAGGED COMBINATORIAL LIBRARY COMPOUNDS | PLOD3, JUND, MRPL21 | HTT 1847/4885MEN1 356/4885THRB 1727/4885 |
| US-20250250568-A1 | MODIFIED OLIGONUCLEOTIDES | TRDMT1, NSUN3, PHAX | HTT 1274/4885MEN1 4299/4885THRB 3420/4885 |
| US-20200263248-A1 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | NT5C3B, POLN, RNGTT | HTT 1443/4885MEN1 4287/4885THRB 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.